Meningococcal vaccine is typically zed as a vaccine used to prevent infection caused by Neisseria meningtidis. This vaccine is given either in the form of injection into the muscle and also under the skin. These vaccines are based on polysaccharide-based, glycoconjugate, protein-based and combined conjugate vaccines, which usually target the pathogen's serogroups. The meningococcal vaccine helps to decline the global incidence of meningococcal meningitis diseases.
According to the Centers for Disease Control and Prevention (CDC) records, about 1.2 million cases of bacterial meningitis are estimated to occur globally each year. Bacterial meningitis can occur at any age. Whereas infants are at a larger risk of developing bacterial meningitis. Numerous campaigns and awareness programs are being organized by several government & non-government organizations.
Data Bridge Market Research analyses a growth rate in the meningococcal vaccines market in the forecast period 2023-2030. The expected CAGR of the meningococcal vaccines market tends to be around 6.7% in the mentioned forecast period. The market was valued at USD 3.07 million in 2022 and would grow to USD 5.16 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific has been witnessing positive growth for the meningococcal vaccines market throughout the forecasted period due to the presence of key manufacturers of the product is high and, increasing research and development activities, healthcare expenditure .
Request a Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-meningococcal-vaccines-market
North America dominates the market due to increased new research and developments on meningococcal vaccines market.
Key players operating in the meningococcal vaccines market include:
Johnson & Johnson Private Limited (U.S.)
Mylan N.V. (U.S.)
Sun Pharmaceutical Industries Limited (India)
Sanofi S.A.(France)
Merck & Co., Inc. (U.S.)
GSK plc (U.K.)
Novartis AG (Switzerland)
AbbVie Inc. (U.S.)
Fresenius Kabi AG (Germany)
Amneal Pharmaceuticals LLC. (U.S.)
Pfizer Inc. (U.S.)
Serum Institute of India Pvt. Ltd (India)
Incepta Pharmaceuticals Ltd. (India)
Walvax Biotechnology Co., Ltd (China)
Bio-Manguinhos (Brazil)
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Global Meningococcal Vaccines Market Size, Trends and Growth Analysis, by Treatment (Meningococcal Conjugate Vaccine, Polysaccharide & Subcapsular Vaccine) and End User (Hospitals & Clinics, Research Laboratories and Academic Institutes) - Forecast till 2027Market HighlightsAccording to Market Research Future (MRFR) analysis, the Meningococcal Vaccines Market 2020 can thrive at a considerable CAGR across the analysis period 2019 to 2025.
By 2025, the meningococcal vaccine market can touch USD Million from USD 172 Million in 2019.The rise in cases of meningococcal disease is expected to support the expansion of the market through the analysis period.
A high number of people have shown resistance to the disorder on vaccination.
However, issues regarding approval of research projects can limit the growth of the meningococcal vaccine market in the years ahead.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8622 Market SegmentationThe segment assessment of the Meningococcal Vaccines global Market is done by treatment type and end-user.The treatment type based segments of the meningococcal market are polysaccharide, sub-capsular vaccine, and meningococcal conjugate vaccine.
The hospitals and clinics segment is expected to significantly control the meningococcal vaccines market in the years to come.
The expansion of the hospitals and clinics segment can be attributed to the rise in the application of vaccines and easy accessibility to healthcare facilities.
